205 related articles for article (PubMed ID: 23539728)
1. SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
He H; Bronisz A; Liyanarachchi S; Nagy R; Li W; Huang Y; Akagi K; Saji M; Kula D; Wojcicka A; Sebastian N; Wen B; Puch Z; Kalemba M; Stachlewska E; Czetwertynska M; Dlugosinska J; Dymecka K; Ploski R; Krawczyk M; Morrison PJ; Ringel MD; Kloos RT; Jazdzewski K; Symer DE; Vieland VJ; Ostrowski M; Jarząb B; de la Chapelle A
J Clin Endocrinol Metab; 2013 May; 98(5):E973-80. PubMed ID: 23539728
[TBL] [Abstract][Full Text] [Related]
2. srGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer.
Feng Y; Feng L; Yu D; Zou J; Huang Z
J Exp Clin Cancer Res; 2016 Dec; 35(1):191. PubMed ID: 27923383
[TBL] [Abstract][Full Text] [Related]
3. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
4. Variants in
Comiskey DF; He H; Liyanarachchi S; Sheikh MS; Genutis LK; Hendrickson IV; Yu L; Brock PL; de la Chapelle A
J Med Genet; 2020 Aug; 57(8):519-527. PubMed ID: 32051256
[TBL] [Abstract][Full Text] [Related]
5. A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition.
Tomsic J; He H; Akagi K; Liyanarachchi S; Pan Q; Bertani B; Nagy R; Symer DE; Blencowe BJ; de la Chapelle A
Sci Rep; 2015 Jul; 5():10566. PubMed ID: 26135620
[TBL] [Abstract][Full Text] [Related]
6. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
7. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
8. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24.
He H; Nagy R; Liyanarachchi S; Jiao H; Li W; Suster S; Kere J; de la Chapelle A
Cancer Res; 2009 Jan; 69(2):625-31. PubMed ID: 19147577
[TBL] [Abstract][Full Text] [Related]
9. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
10. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Wójcicka A; Czetwertyńska M; Świerniak M; Długosińska J; Maciąg M; Czajka A; Dymecka K; Kubiak A; Kot A; Płoski R; de la Chapelle A; Jażdżewski K
Genes Chromosomes Cancer; 2014 Jun; 53(6):516-23. PubMed ID: 24599715
[TBL] [Abstract][Full Text] [Related]
11. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
12. The Role of NRG1 in the Predisposition to Papillary Thyroid Carcinoma.
He H; Li W; Liyanarachchi S; Wang Y; Yu L; Genutis LK; Maharry S; Phay JE; Shen R; Brock P; de la Chapelle A
J Clin Endocrinol Metab; 2018 Apr; 103(4):1369-1379. PubMed ID: 29121253
[TBL] [Abstract][Full Text] [Related]
13. Variants in microRNA genes in familial papillary thyroid carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; Genutis LK; Wang Y; Li W; Volinia S; Jazdzewski K; He H; Wakely PE; Senter L; de la Chapelle A
Oncotarget; 2017 Jan; 8(4):6475-6482. PubMed ID: 28031538
[TBL] [Abstract][Full Text] [Related]
14. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
[TBL] [Abstract][Full Text] [Related]
15. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
Costa V; Esposito R; Ziviello C; Sepe R; Bim LV; Cacciola NA; Decaussin-Petrucci M; Pallante P; Fusco A; Ciccodicola A
Oncotarget; 2015 May; 6(13):11242-51. PubMed ID: 25803323
[TBL] [Abstract][Full Text] [Related]
16. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
Elisei R; Viola D; Torregrossa L; Giannini R; Romei C; Ugolini C; Molinaro E; Agate L; Biagini A; Lupi C; Valerio L; Materazzi G; Miccoli P; Piaggi P; Pinchera A; Vitti P; Basolo F
J Clin Endocrinol Metab; 2012 Dec; 97(12):4390-8. PubMed ID: 23066120
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
18. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
[TBL] [Abstract][Full Text] [Related]
19. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer.
Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
[TBL] [Abstract][Full Text] [Related]
20. BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.
Rusinek D; Swierniak M; Chmielik E; Kowal M; Kowalska M; Cyplinska R; Czarniecka A; Piglowski W; Korfanty J; Chekan M; Krajewska J; Szpak-Ulczok S; Jarzab M; Widlak W; Jarzab B
PLoS One; 2015; 10(12):e0143688. PubMed ID: 26625260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
